Inhibitory Potential of Benzo[a]phenazin-۵-ol Derivatives Against C-Kit Kinase: Molecular Docking and Prediction of ADME/Drug-Likeness Properties
محل انتشار: مجله علوم پیشرفته زیست پزشکی، دوره: 14، شماره: 3
سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 136
فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JABS-14-3_006
تاریخ نمایه سازی: 13 آبان 1403
چکیده مقاله:
Background & Objectives: C-Kit, a receptor tyrosine kinase involved in intracellular signaling, has a mutated form that significantly contributes to the development of certain cancers. This study aimed to evaluate a series of benzo[a]phenazin-۵-ol-tethered tri-substituted methane derivatives as potential pharmacophores for inhibiting C-Kit kinase.
Materials & Methods: Benzo[a]phenazine-۵-ol derivatives were sketched and converted into Mol۲ files using Marvin software. Their three dimensional (۳D) structures were generated and saved in PDB format. Molecular docking studies with the C-Kit kinase (PDB code ۱t۴۶) were performed using AutoDock ۴.۲. Additionally, the derivatives' physicochemical properties, ADME characteristics, and drug-likeness parameters were assessed with the SwissADME online tool.
Results: Molecular docking studies of benzo[a]phenazin-۵-ol derivatives (A-L) against C-kit kinase revealed that compounds A and C exhibited greater selectivity and stronger inhibitory effects than the reference drug, Sunitinib. Ligplot analysis demonstrated that compound A formed four hydrogen bonds with Arg۷۹۱(A), Ile۷۸۹(A), and His۷۹۰(A), while compound C formed two hydrogen bonds with Ile۵۷۱(A) and Ile۷۸۹(A). ADME analysis indicated that all compounds, except C, D, and I, are potential P-gp substrates. Drug-likeness analysis showed one or two violations of Lipinski's rule of five.
Conclusion: In summary, molecular docking studies identified compounds A and C as promising lead candidates for inhibiting C-kit kinase, demonstrating superior binding to the active site compared to Sunitinib. ADME and drug-likeness analysis revealed that compound A is a potential P-gp substrate with one violation of Lipinski's rule of five, making it the closest pharmacological match to Sunitinib and a strong candidate for further investigation.
کلیدواژه ها:
نویسندگان
ابوالفضل علیائی
Department of Chemistry, Faculty of Science, Imam Khomeini International University, Qazvin, Iran
منیر شالبافان
Department of Chemistry, Faculty of Science, Imam Khomeini International University, Qazvin, Iran
فاطمه رحیمی
Department of Chemistry, Faculty of Science, Imam Khomeini International University, Qazvin, Iran
مهدیه صادق پور
Department of Chemistry, Qazvin Branch, Islamic Azad University, Qazvin, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :